New York-based Mantra Health, a behavioral health tool focused on college students, is expanding its serious mental illness services, with its new program designed to support individuals with bipolar I disorder. This comes a year after the tech company added a service that supports patients with bipolar II disorder.
Mantra is able to integrate with their clients' University Health Services to...
Personal genetics company 23andMe will be teaming up with the Milken Institute, a think tank, and pharmaceutical company Lundbeck to drive enrollment for a genetic study designed to grasp the underlying biology of major depressive and bipolar disorders.
The study will combine cognitive assessments with genetic data and survey responses to assess how genes influence brain processes -- such as...
Proteus Digital Health, the ingestible sensor company that raised $45 million in May -- the largest funding raise in digital health this year so far -- has published the results of a small clinical trial in a peer-reviewed journal. The study of 27 adults with bipolar disorder or schizophrenia found that the addition of an ingestible sensor to their regiment led to 67 percent of patients taking...
